Lupin board to consider unaudited financial results

16 Jan 2013 Evaluate

Lupin has informed that a meeting of the board of directors of the company will be held on January 31, 2013, to consider and take on record unaudited financial results for the quarter ended December 31, 2012 (Q3).

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2101.75 -10.25 (-0.49%)
01-Jan-2026 14:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1718.85
Dr. Reddys Lab 1250.30
Cipla 1499.60
Zydus Lifesciences 913.35
Lupin 2101.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×